Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2019

Feb 8, 2019

31799_dirs_2019-02-08_6eafee00-0be1-4d8e-802e-72a0722393fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2019-02-06

Reporting Person: Colangelo Dominick (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-06 Stock Option (right to buy) $16.66 A 6002 Acquired 2029-02-06 Common Stock (6002) Direct
2019-02-06 Restricted Stock Unit $ A 27750 Acquired Common Stock (27750) Direct
2019-02-06 Stock Option (right to buy) $16.66 A 303998 Acquired 2029-02-06 Common Stock (303998) Direct

Footnotes

F1: These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.

F3: These RSUs vest in four annual installments with 6,937 RSUs vesting on February 6, 2020, 6,938 RSUs vesting on February 6, 2021, 6,937 RSUs vesting on February 6, 2022, and 6,938 RSUs vesting on February 6, 2023.

F4: No expiration date for this type of award.